- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 265/04 - 1,3-OxazinesHydrogenated 1,3-oxazines
Patent holdings for IPC class C07D 265/04
Total number of patents in this class: 8
10-year publication summary
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Samsung Electronics Co., Ltd. | 154120 |
1 |
| Hoffmann-La Roche Inc. | 3696 |
1 |
| Novartis Pharma AG | 180 |
1 |
| Bayer Cropscience AG | 1887 |
1 |
| Council of Scientific and Industrial Research | 578 |
1 |
| Rutgers, The State University of New Jersey | 1959 |
1 |
| Siena Biotech S.p.A. | 33 |
1 |
| Bicyclerd Limited | 150 |
1 |
| Other owners | 0 |